.
MergerLinks Header Logo

New Deal


Announced

Dermapharm to acquire Arkopharma from Montagu for £375m.

Financials

Edit Data
Transaction Value£375m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Single Bidder

Private Equity

Pending

Majority

Acquisition

Cross Border

pharmaceutical company

Friendly

Pharmaceuticals

France

Private

Synopsis

Edit

Dermapharm, a provider of pharmaceutical products, agreed to acquire Arkopharma, a manufacturer of pharmaceutical, medical and beauty products, from Montagu, a European private equity firm, for £375m. “Arkopharma is a great example of Montagu’s strategy of partnering with high-quality healthcare companies in their pursuit of growth. We are proud of the success Arkopharma has achieved, and we are certain that the Company will continue to thrive under the ownership of Dermapharm. We would especially like to thank the management team and all Arkopharma’s employees for their hard work and dedication, and we wish them all the best on their future journey," Guillaume Jabalot, Montagu Director.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US